New drug tested for rare energy disorder
NCT ID NCT05972954
Summary
This study tested an experimental drug called OMT-28 for people with primary mitochondrial disease, a rare condition where the body's energy-producing cells don't work properly. Researchers gave 28 patients the daily medication for 6 months to check if it was safe, reduced certain blood markers of disease, and helped with symptoms like fatigue. They compared results from the treatment period to a prior 3-month period when patients received only standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MITOCHONDRIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliero Universitaria Pisana, P.O. Santa Chiara, U.O. Neurologia, Edificio 13, Via Roma 67
Pisa, 56126, Italy
-
Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU Klinikum), Ziemssenstr. 1a
Munich, 80336, Germany
-
IRCCS Institute of Neurological Science of Bologna, University of Bologna, Department of Biomedical and Neuromotor Science (DIBINEM), Ospedale Bellaria Via Altura, 3
Bologna, 40139, Italy
-
IRCCS Istituto Neurologico Carlo Besta, SC Servizio Di Medicina Di Laboratorio - Genetica Medica E Neurogenetica, Via Celoria 11
Milan, 20133, Italy
-
Medizinisch Fakultät der Martin-Luther-Universität Halle-Wittenberg Universitätsklinik und Poliklinik für Neurologie Universitätsklinikum , Ernst-Grube-Str. 40
Halle, 06120, Germany
-
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, 6500 HB, Netherlands
-
U.O.C. di Neurologia e Malattie Neuromuscolari
Messina, 98125, Italy
-
UOC di neurofisiopatologia
Roma, 8-00168, Italy
-
Universitätsklinikum Bonn, Sektion Neuromuskuläre Erkrankungen, Klinik und Poliklinik für Neurologie, Venusberg-Campus 1, Gebäude 80, NPP
Bonn, 53127, Germany
Conditions
Explore the condition pages connected to this study.